Back

Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

27 August 2016 (14:06 - 14:24)
Organised by:
Congress Presentation Part of: Drug - Eluting stent PCI / stents: devices and technique ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Elmir Omerovic

Sahlgrenska University Hospital, Gothenburg (Sweden)

4 More presentations in this session

Presentation thumbnail
State of the art in drug eluting stent technology.
Professor R. Byrne (Dublin, IE)
Slides Video
Presentation thumbnail
Ten year clinical outcome of a large registry with unrestricted use of DES
Professor R. van Geuns (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes of biolimus-eluting stents with biodegradable versus bare-metal stents in patients with acute STEMI: 5 Year results of the randomized COMFORTABLE AMI trial.
Doctor L. Raber (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Future direction for research in drug - eluting stent technology.
Doctor M. Morice (Massy, FR)
Slides Video

Access the full session

Session thumbnail
Drug - Eluting stent

The Event

Event poster

ESC Congress 2016

27 August 2016 14:06 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources